Antimicrobial Resistance Defense Stack
We are walking into a post-antibiotic world, but we still operate hospitals and drug markets as if antibiotics are an infinite, cheap, reliable substrate.
The Stakes
Antimicrobial resistance (AMR) is a compounding failure mode. It turns routine surgery, childbirth, chemotherapy, and intensive care into higher-risk bets. It is also a national resilience issue: brittle supply of effective antibiotics is a single point of failure for modern medicine and military readiness.
Headline evidence
- •In 2019, bacterial AMR caused an estimated 1.27 million deaths directly and was associated with 4.95 million deaths globally. [1]
- •In 2023, about 1 in 6 lab-confirmed bacterial infections causing common syndromes were resistant to antibiotic treatment, based on WHO GLASS surveillance. [2]
- •WHO’s 2025 global surveillance analysis draws on over 23 million bacteriologically confirmed cases, reported by 104 countries in 2023. [3]
Neglectedness
Why it stays neglected
This is classic market failure. The best antibiotic is the one you do not use, but revenue depends on volume. Hospitals buy on price, not long-run effectiveness. Data is fragmented across labs and countries. A lot of AMR value is negative space: infections that never happen, outbreaks that never start, resistance that never spreads.
Tractability
Hard, but no longer blocked. Sequencing, rapid diagnostics, and machine learning triage are improving. The WHO GLASS data spine is maturing, but still uneven. The hard parts are incentives, procurement, and scaling diagnostics into routine workflows without adding clinician burden.
Startup surfaces
- •Point-of-care rapid susceptibility testing that fits triage and inpatient flow
- •Hospital antibiotic decision systems that learn local resistance patterns in real time
- •Pathogen-focused “defense bundles” for highest-burden syndromes (sepsis, pneumonia, urinary tract infections)
- •Novel-payment and procurement tooling for “pull incentives” and subscription models
- •Environmental AMR monitoring for wastewater, farms, and hospitals tied to interventions
Source Stack (4)
- [1] Murray CJL et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. (2022). Lancet )
- [2] WHO. WHO warns of widespread resistance to common antibiotics worldwide (news release, 13 Oct 2025). (who.int )
- [3] WHO. Global antibiotic resistance surveillance report 2025 (GLASS). (Oct 2025). (who.int )
- [4] WHO. Antimicrobial resistance fact sheet (updated). (who.int )
Builder Proof-of-Work
Community submitted artifacts, notes, and implementations for this idea.